BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Inflammatory disorder
,
Endothelial cell
,
Pharmacogenetics
,
Clofibrate
,
rs4950928
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Jag1
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Conjunctiva
Aorta
Penis
Vagina
Urethra
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Congenital biliary atresia
Ventricular septal defect
Carditis
Endocarditis
Immunoglobulin G4 deficiency
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Idoxuridine
2-chloro-5-nitrobenzanilide
JAG1 protein, human
Gonadotropins, Equine
Viomycin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Idd1
Idd5
TRIB2
ZNF32
JAG1
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Jag1-Notch cis-interaction determines cell fate segregation in pancreatic development.
Generation of JAG1 gene c.1615C > T heterozygous mutation human embryonic stem cell line (SDQLCHe001…
MiR-203a-5p Inhibits Multiple Myeloma Cell Proliferation and Cell Cycle Progression via Targeting JA…
Cyclin B2 overexpression promotes tumour growth by regulating jagged 1 in hepatocellular carcinoma.
Exosomes from hypoxia-conditioned apical papilla stem cells accelerate angiogenesis in vitro through…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
RO4929097 and Erlotinib Hydrochloride in Treating Patients With Stage IV or Recurrent Non-small Cell…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ